Primary diffuse large B-Cell lymphoma of the testis

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 10, 2011, Pages 1363-1367

  Horne, Matthew J ^a   Adeniran, Adebowale J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; LARGE CELL LYMPHOMA; MALE; MUTATION; PATHOLOGY; PROGNOSIS; PROTO ONCOGENE; TESTIS TUMOR;

DIAGNOSIS, DIFFERENTIAL; GENES, BCL-2; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MUTATION; PROGNOSIS; TESTICULAR NEOPLASMS;

EID: 80055089616     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2010-0158-RS     Document Type: Article

References (34)

1. Shahab N, Doll DC. Testicular lymphoma. Semin. Oncol. 1999;26(3):259-269. (Pubitemid 29272894)
2. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8(8):727-737. (Pubitemid 27397895)
3. Swerdlow SH, Campo E, Harris NL, et al. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008 World Health Organization Classification of Tumors.
4. Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord: a clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol. 1994;18(4):376-390. (Pubitemid 24093602)
5. Heller KN, Teruya-Feldstein J, La Quaglia MP, Wexler LH. Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy. ; Pediatr Hematol Oncol. 2004;26(2):104-107. (Pubitemid 38186265)
6. Kremer M, Ott G, Nathrath M, et al. Primary extramedullar plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol. 2005;205(1):92-101. (Pubitemid 40029097)
7. Miedler JD, MacLennan GT. Primary testicular lymphoma. J Urol. 2007; 178(6):2645. (Pubitemid 350052248)
8. Vitolo U, Ferreri AJ, Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol. 2008;65(2):183-189.
9. Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: a populationbased study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer. 1994;30A(12):1760-1764. (Pubitemid 24377147)
10. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med. 1986; 81 (3):515-524. (Pubitemid 16003877)
11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
12. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000,88(1): 154-161. (Pubitemid 30027691)
13. Hasselblom S, Ridell B, Wedel H, Norrby K, Sender Baum M, Ekman T. Testicular lymphoma-a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol. 2004;43(8):758-765. (Pubitemid 40066019)
14. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003;21(1):20-27.
15. Ulbright TM, Amin MB, Young RH. Tumors of the Testis, Adnexa, Spermatic Cord and Scrotum. Washington, DC: American Registry of Pathology; Atlas of Tumor Pathology, 3rd series, fascicle 25.
16. Paladugu RR, Bearman RM, Rappaport H. Malignant lymphoma with primary manifestation in the gonad: a clinicopathologic study of 38 patients. Cancer. 1980;45(3):561-571. (Pubitemid 10169306)
17. Turner RR, Colby TV, MacKintosh FR. Testicular lymphomas: a clinicopathologic study of 35 cases. Cancer. 1981;48(9):2095-2102. (Pubitemid 12231568)
18. Loddenkemper C, Anagnostopoulos I, Hummel M, et al. Differential Emuenhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004;202(1):60-69. (Pubitemid 38072846)
19. Tagawa H, Suguro M, Tsuzuki S, et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood. 2005;106(5):1770-1777. (Pubitemid 41208593)
20. Berglund M, Thunberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol. 2005;18(8):1113-1120. (Pubitemid 41224503)
21. Colomo L, López-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood. 2003;101(1):78-84. (Pubitemid 36025890)
22. Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki- 67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood. 1994,83(6): 1460-1466. (Pubitemid 24081556)
23. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(25):1937-1947. (Pubitemid 34651353)
24. Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases. Mod Pathol. 2006;19(12):1521-1527. (Pubitemid 44789919)
25. Bosga-Bouwer AG, Kok K, Booman M, et al. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma. Genes Chromosomes Cancer. 2006; 45(10):976-981. (Pubitemid 44360185)
26. Rrckert CH, Dockhorn-Dworniczak B, Simon R, Paulus W. Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol. 1999;155(5):1445-1451.
27. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve geneexpression- based survival prediction. Blood. 2005; 106(9):3183-3190. (Pubitemid 41565917)
28. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998; 92(9):3152-3162. (Pubitemid 28492322)
29. Tanaka S, Louie DC, Kant JA, Reed JC. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood. 1992;79(1):229-237.
30. Tondini C, Ferreri AJ, Siracusano L, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol. 1999; 17(9):2854-2858. (Pubitemid 29415244)
31. Linassier C, Desablens B, Lefrancq T, et al; GOELAMS Study Group. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. Clin Lymphoma. 2002;3(3):167-172. (Pubitemid 36113688)
32. Coiffier B. Rituximab therapy in malignant lymphoma. Oncogene. 2007; 26(25):3603-3613. (Pubitemid 46844778)
33. Sussman EB, Hajdu SI, Lieberman PH, Whitmore WF. Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. J Urol. 1977; 118(6): 1004-1007. (Pubitemid 8261176)
34. Ulbright TM. The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them. Adv Anat Pathol. 2008;15(1): 18-27. (Pubitemid 351627650)